Aequim Alternative Investments’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Aequim Alternative Investments's CPUH.WS Position: Q3 2023 in Review
Aequim Alternative Investments sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q3 2023, closing a stake of 200,000 shares — an estimated $100K sold.
Aequim Alternative Investments first reported a position in CPUH.WS in Q1 2022 and held it in 6 quarters. The position peaked at $100K in Q2 2023. 0 funds tracked by Wall St. Rank hold CPUH.WS as of Q3 2023.
- Aequim Alternative Investments reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
- Aequim Alternative Investments sold 200,000 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2023, an estimated $100K.
- Aequim Alternative Investments first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 6 quarters.
- Aequim Alternative Investments's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $100K in Q2 2023.
- 0 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2023.
Based on Aequim Alternative Investments's 13F filing for Q3 2023, filed 15 Nov 2023.